HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Azilsartan attenuates cardiac damage caused by high salt intake through the downregulation of the cardiac (pro)renin receptor and its downstream signals in spontaneously hypertensive rats.

Abstract
We examined whether the stimulation of the angiotensin II AT1 receptor increases the expression of the cardiac (pro)renin receptor ((P)RR) and its downstream signals and whether the blockade of the angiotensin II AT1 receptor by azilsartan decreases the expression of the cardiac (P)RR and its signaling in spontaneously hypertensive rats (SHRs) with a high-salt intake. Rats received normal-salt (0.9%) chow, high-salt (8.9%) chow, normal-salt chow with 1 mg/day of azilsartan, and high-salt chow with 1 mg/day of azilsartan from 6 to 12 weeks of age. Rats with normal-salt chow were administered 100 ng/kg/min of angiotensin II by osmotic minipump from 6 to 12 weeks of age. A high-salt diet and angiotensin II significantly increased the systolic blood pressure; overexpressed cardiac (P)RR, phosphorylated (p)-ERK1/2, p-p38MAPK, p-HSP27, and TGF-ß1; enhanced cardiac interstitial and perivascular fibrosis, cardiomyocyte size, interventricular septum (IVS) thickness, and left ventricular (LV) end-diastolic dimension; and decreased LV fractional shortening. Azilsartan decreased systolic blood pressure, cardiac expressions of (P)RR, p-ERK1/2, p-p38MAPK, p-HSP27, and TGF-ß1, cardiac interstitial and perivascular fibrosis, cardiomyocyte size, and LV diastolic dimension, and improved LV fractional shortening. In conclusion, azilsartan attenuates cardiac damage caused by high salt intake through the downregulation of the cardiac (pro)renin receptor and its downstream signals in SHRs.
AuthorsHisaaki Komaki, Masamitsu Iwasa, Yuka Hayakawa, Chihiro Okamoto, Shingo Minatoguchi, Yoshihisa Yamada, Hiromitsu Kanamori, Masanori Kawasaki, Kazuhiko Nishigaki, Shinya Minatoguchi
JournalHypertension research : official journal of the Japanese Society of Hypertension (Hypertens Res) Vol. 41 Issue 11 Pg. 886-896 (Nov 2018) ISSN: 1348-4214 [Electronic] England
PMID30209283 (Publication Type: Journal Article)
Chemical References
  • Angiotensin II Type 1 Receptor Blockers
  • Benzimidazoles
  • Oxadiazoles
  • Receptors, Cell Surface
  • Sodium Chloride, Dietary
  • Transforming Growth Factor beta1
  • Angiotensin II
  • azilsartan
  • Prorenin Receptor
Topics
  • Angiotensin II
  • Angiotensin II Type 1 Receptor Blockers (pharmacology, therapeutic use)
  • Animals
  • Benzimidazoles (pharmacology, therapeutic use)
  • Blood Pressure (drug effects)
  • Down-Regulation (drug effects)
  • Heart (drug effects)
  • Hypertension (chemically induced, drug therapy, metabolism)
  • Myocardium (metabolism)
  • Oxadiazoles (pharmacology, therapeutic use)
  • Phosphorylation (drug effects)
  • Rats
  • Rats, Inbred SHR
  • Receptors, Cell Surface (genetics, metabolism)
  • Signal Transduction (drug effects)
  • Sodium Chloride, Dietary (adverse effects)
  • Transforming Growth Factor beta1 (metabolism)
  • Prorenin Receptor

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: